BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36217128)

  • 1. B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition.
    Yan X; Hong B; Feng J; Jin Y; Chen M; Li F; Qian Y
    BMC Cancer; 2022 Oct; 22(1):1053. PubMed ID: 36217128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness.
    Feng Y; Yang Z; Zhang C; Che N; Liu X; Xuan Y
    Pathol Res Pract; 2021 Feb; 218():153323. PubMed ID: 33429327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma.
    Hwang C; Lee HJ; Na JY; Kim KH; Song YJ; Kim JY; Kim K; Shin DH; Park JY; Kim SY; Lee JH; Choi KU
    J Ovarian Res; 2023 Jan; 16(1):3. PubMed ID: 36609273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7 family member H4 induces epithelial-mesenchymal transition and promotes the proliferation, migration and invasion of colorectal cancer cells.
    Yin Y; Shi L; Yang J; Wang H; Yang H; Wang Q
    Bioengineered; 2022 Jan; 13(1):107-118. PubMed ID: 34818980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
    Xiao S; Liu L; Lu X; Long J; Zhou X; Fang M
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1465-74. PubMed ID: 25716692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.
    Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C
    Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of B7-H4 is associated with infiltrating immune cells and poor prognosis in metastatic colorectal cancer.
    Ding S; Lv X; Liu Z; Zhan S; Xu Y; Zhang X; Liu C; Cao L
    Int Immunopharmacol; 2021 Jan; 90():107144. PubMed ID: 33187907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
    Gao ZH; Lu C; Wang ZN; Song YX; Zhu JL; Gao P; Sun JX; Chen XW; Wang MX; Dong YL; Xu HM
    Histopathology; 2014 Oct; 65(4):527-38. PubMed ID: 24738665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
    Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
    Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
    Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
    Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
    Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
    Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
    Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
    Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
    Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
    Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin-C as a prognostic determinant of colorectal cancer through induction of epithelial-to-mesenchymal transition and proliferation.
    Yang Z; Zhang C; Qi W; Cui C; Cui Y; Xuan Y
    Exp Mol Pathol; 2018 Oct; 105(2):216-222. PubMed ID: 30170017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.
    Gao T; Wang M; Xu L; Wen T; Liu J; An G
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2131-40. PubMed ID: 27520310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma.
    Lu Z; Zhao ZX; Cheng P; Huang F; Guan X; Zhang MG; Chen HP; Liu Z; Jiang Z; Zheng ZX; Zou SM; Wang XS
    Mod Pathol; 2020 Nov; 33(11):2330-2340. PubMed ID: 32514163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
    Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
    Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
    Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
    Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.